• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意义未明的单克隆丙种球蛋白病患者的特征与进展为多发性骨髓瘤之间的关联:一项系统评价

Associations Between Patient Characteristics and Progression to Multiple Myeloma Among Patients With Monoclonal Gammopathy of Undetermined Significance: A Systematic Review.

作者信息

Li Yimeng, Hsu Sylvia H, Wang Rong, Theprungsirikul Poy, Neparidze Natalia, Chang Su-Hsin, Wang Shi-Yi

机构信息

Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT.

Schulich School of Business, York University, Toronto, Canada.

出版信息

Clin Lymphoma Myeloma Leuk. 2025 Apr;25(4):e222-e231. doi: 10.1016/j.clml.2024.12.006. Epub 2024 Dec 6.

DOI:10.1016/j.clml.2024.12.006
PMID:39730300
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11911095/
Abstract

Monoclonal gammopathy of undetermined significance (MGUS) is a pre-malignant condition of multiple myeloma (MM). Evidence suggested old age, black race, male gender, and obesity as risk factors for MGUS development; however, whether they are associated with an increased risk of progression to MM among patients with MGUS is unclear. A systematic search of PUBMED and EMBASE for cohort studies investigating the association between age/race/gender/obesity and progression to MM. We used the Newcastle-Ottawa Scale (NOS) to assess the methodologic quality of the included studies. Summary risk ratios were calculated using random-effects models. We identified 24 publications, of which 17 articles were included in the main analyses. Overall, the quality of the studies was fair (mean NOS = 5.5). Our meta-analyses showed that old age was positively associated with the risk of the MGUS-MM progression (risk ratio: 2.38; 95% confidence interval [CI] 1.59-3.57), while race was not statistically significantly associated with the risk (blacks vs whites: 1.09; 95% CI: 0.77-1.54). Males had a lower risk of MGUS-MM progression, compared to females (risk ratio: 0.70; 95% CI 0.50-1.0; P-value = .048). High body mass index was significantly associated with an increased risk of MGUS-MM progression (risk ratio: 1.32; 95% CI 1.12-1.57). Based on extant research, old age, female sex, and obesity may be implicated in MGUS-MM progression. However, several studies which found an insignificant association between age/gender and progression did not report the risk estimates. Publication bias exists and our risk estimates may be overestimated. More studies are warranted to confirm our findings.

摘要

意义未明的单克隆丙种球蛋白病(MGUS)是多发性骨髓瘤(MM)的一种癌前状态。有证据表明,老年、黑人种族、男性以及肥胖是MGUS发生的危险因素;然而,它们是否与MGUS患者进展为MM的风险增加相关尚不清楚。我们对PUBMED和EMBASE进行了系统检索,以查找调查年龄/种族/性别/肥胖与进展为MM之间关联的队列研究。我们使用纽卡斯尔-渥太华量表(NOS)来评估纳入研究的方法学质量。使用随机效应模型计算汇总风险比。我们识别出24篇出版物,其中17篇文章纳入主要分析。总体而言,研究质量为中等(平均NOS = 5.5)。我们的荟萃分析表明,老年与MGUS进展为MM的风险呈正相关(风险比:2.38;95%置信区间[CI] 1.59 - 3.57),而种族与该风险无统计学显著关联(黑人与白人相比:1.09;95% CI:0.77 - 1.54)。与女性相比,男性MGUS进展为MM的风险较低(风险比:0.70;95% CI 0.50 - 1.0;P值 = 0.048)。高体重指数与MGUS进展为MM的风险增加显著相关(风险比:1.32;95% CI 1.12 - 1.57)。基于现有研究,老年、女性性别以及肥胖可能与MGUS进展为MM有关。然而,一些发现年龄/性别与进展之间无显著关联的研究未报告风险估计值。存在发表偏倚,我们的风险估计值可能被高估。需要更多研究来证实我们的发现。

相似文献

1
Associations Between Patient Characteristics and Progression to Multiple Myeloma Among Patients With Monoclonal Gammopathy of Undetermined Significance: A Systematic Review.意义未明的单克隆丙种球蛋白病患者的特征与进展为多发性骨髓瘤之间的关联:一项系统评价
Clin Lymphoma Myeloma Leuk. 2025 Apr;25(4):e222-e231. doi: 10.1016/j.clml.2024.12.006. Epub 2024 Dec 6.
2
Bisphosphonates in multiple myeloma: an updated network meta-analysis.双膦酸盐类药物在多发性骨髓瘤中的应用:一项更新的网状Meta分析
Cochrane Database Syst Rev. 2017 Dec 18;12(12):CD003188. doi: 10.1002/14651858.CD003188.pub4.
3
Bisphosphonates in multiple myeloma: a network meta-analysis.双膦酸盐类药物治疗多发性骨髓瘤:一项网状Meta分析
Cochrane Database Syst Rev. 2012 May 16(5):CD003188. doi: 10.1002/14651858.CD003188.pub3.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Plasma Proteomic Profiles Among White and African American Individuals With Monoclonal Gammopathy of Unknown Significance (MGUS) and Multiple Myeloma (MM).意义未明的单克隆丙种球蛋白病(MGUS)和多发性骨髓瘤(MM)的白种人和非裔美国人的血浆蛋白质组学图谱。
Clin Lymphoma Myeloma Leuk. 2025 Jun 14. doi: 10.1016/j.clml.2025.06.008.
8
Sex as a prognostic factor for mortality in adults with acute symptomatic pulmonary embolism.性别作为急性症状性肺栓塞成年患者死亡率的一个预后因素。
Cochrane Database Syst Rev. 2025 Mar 20;3(3):CD013835. doi: 10.1002/14651858.CD013835.pub2.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
10
Sex and gender as predictors for allograft and patient-relevant outcomes after kidney transplantation.性别作为肾移植后同种异体移植及患者相关预后的预测因素。
Cochrane Database Syst Rev. 2024 Dec 19;12(12):CD014966. doi: 10.1002/14651858.CD014966.pub2.

本文引用的文献

1
Asymptomatic Incidence of Monoclonal Gammopathy of Undetermined Significance and Preclinical Duration to Myeloma Diagnosis: A Modeling Study.意义未明的单克隆丙种球蛋白病的无症状发病率及骨髓瘤诊断的临床前期病程:一项建模研究
Cancer Epidemiol Biomarkers Prev. 2024 Dec 2;33(12):1690-1697. doi: 10.1158/1055-9965.EPI-24-0490.
2
The Association of Agent Orange Exposure with the progression of monoclonal gammopathy of undetermined significance to multiple myeloma: a population-based study of Vietnam War Era Veterans.接触橙剂与意义未明的单克隆丙种球蛋白病进展为多发性骨髓瘤的关联:一项对越南战争时期退伍军人的基于人群的研究。
J Hematol Oncol. 2024 Jan 8;17(1):3. doi: 10.1186/s13045-023-01521-6.
3
Disentangling age, gender, and racial/ethnic disparities in multiple myeloma burden: a modeling study.解析多发性骨髓瘤负担中的年龄、性别和种族/民族差异:一项建模研究。
Nat Commun. 2023 Sep 20;14(1):5768. doi: 10.1038/s41467-023-41223-8.
4
Mortality in the US Populations With Monoclonal Gammopathy of Undetermined Significance.意义未明单克隆丙种球蛋白病美国人群中的死亡率
JAMA Oncol. 2023 Sep 1;9(9):1293-1295. doi: 10.1001/jamaoncol.2023.2278.
5
It is worth the weight: obesity and the transition from monoclonal gammopathy of undetermined significance to multiple myeloma.值得重视:肥胖与意义未明的单克隆丙种球蛋白血症向多发性骨髓瘤的转化。
Blood Adv. 2023 Sep 26;7(18):5510-5523. doi: 10.1182/bloodadvances.2023010822.
6
Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM study.无法确定意义的单克隆丙种球蛋白血症的疾病相关性只能通过筛查队列来评估:基于人群的 iStopMM 研究结果。
Haematologica. 2023 Dec 1;108(12):3392-3398. doi: 10.3324/haematol.2023.283191.
7
Obesity and multiple myeloma: Emerging mechanisms and perspectives.肥胖与多发性骨髓瘤:新出现的机制与观点
Semin Cancer Biol. 2023 Jul;92:45-60. doi: 10.1016/j.semcancer.2023.04.003. Epub 2023 Apr 6.
8
Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study.伴意义未明单克隆丙种球蛋白血症或冒烟型多发性骨髓瘤患者的个体化进展预测(PANGEA):一项回顾性、多队列研究。
Lancet Haematol. 2023 Mar;10(3):e203-e212. doi: 10.1016/S2352-3026(22)00386-6.
9
Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota.明尼苏达州奥姆斯特德县的体重指数与意义未明的单克隆丙种球蛋白病(MGUS)进展相关。
Blood Cancer J. 2022 Apr 19;12(4):67. doi: 10.1038/s41408-022-00659-9.
10
Body mass index and risk of progression from monoclonal gammopathy of undetermined significance to multiple myeloma: Results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.体重指数与意义未明的单克隆丙种球蛋白病进展为多发性骨髓瘤的风险:前列腺、肺、结直肠癌和卵巢癌筛查试验的结果
Blood Cancer J. 2022 Apr 1;12(4):51. doi: 10.1038/s41408-022-00642-4.